Outset Medical, Inc. (OM) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	117.8M	119.5M	113.7M	130.4M	115.4M
Cost of Revenue	68.6M	72.7M	75.1M	101.4M	97.5M
Gross Profit	49.2M	46.8M	38.6M	29.0M	17.8M
Operating Expenses
R&D Expense	21.5M	21.2M	38.4M	57.3M	48.9M
SG&A Expense	93.7M	92.2M	113.5M	141.5M	130.0M
General & Admin Expense	41.9M	37.9M	43.5M	45.2M	40.5M
Selling & Marketing Expense	51.9M	54.4M	70.0M	96.2M	89.5M
Other Expenses	—	—	—	—	—
Total Operating Expenses	115.2M	113.5M	151.9M	198.8M	178.9M
Cost and Expenses	183.8M	186.2M	227.1M	300.1M	276.4M
Operating Income (EBIT)	(66.0M)	(66.7M)	(113.4M)	(169.8M)	(161.0M)
Non-Operating
Interest Income	5.1M	7.4M	9.8M	10.2M	3.3M
Interest Expense	13.7M	14.0M	23.9M	12.7M	3.6M
Net Interest Income	(8.7M)	(6.5M)	(14.1M)	(2.5M)	(275.0K)
Other Non-Op Income/Expense	(7.3M)	(14.2M)	(14.1M)	(2.5M)	(1.6M)
Non-Operating Income (excl Interest)	(6.4M)	8.0K	(5.6M)	(10.2M)	(1.9M)
EBT (Pre-Tax Income)	(73.4M)	(80.9M)	(127.5M)	(172.3M)	(162.7M)
Income Tax Expense	936.0K	718.0K	491.0K	523.0K	295.0K
Bottom Line
Net Income	(74.3M)	(81.7M)	(128.0M)	(172.8M)	(163.0M)
Earnings from Cont. Ops	(74.3M)	(81.7M)	(128.0M)	(172.8M)	(163.0M)
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	(74.3M)	(81.7M)	(128.0M)	(172.8M)	(163.0M)
Per Share
Basic EPS	($4.09)	($5.37)	($36.95)	($52.27)	($50.75)
Diluted EPS	($4.09)	($5.37)	($36.95)	($52.27)	($50.75)
Revenue Per Share	$6.33	$7.85	$32.83	$39.44	$35.93
Shares
Basic Shares Outstanding	18.6M	15.2M	3.5M	3.3M	3.2M
Diluted Shares Outstanding	18.6M	15.2M	3.5M	3.3M	3.2M
Profitability Metrics
EBITDA	(56.2M)	(62.4M)	(102.1M)	(153.8M)	(152.8M)
D&A	3.4M	4.3M	5.7M	5.8M	6.3M
EBIT	(59.6M)	(66.7M)	(107.8M)	(159.6M)	(159.1M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026